Global Vaccine Market Research Report 2024(Status and Outlook)
Report Overview
Vaccines play a crucial role in preventing and controlling infectious diseases by stimulating the immune system to recognize and fight specific pathogens. The global vaccine market encompasses a wide range of products designed to prevent various diseases, including but not limited to influenza, hepatitis, measles, and human papillomavirus.
As of 2023, the global vaccine market size stands at approximately $60 billion. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.5% from 2024 to 2032. Several factors are driving this growth, including increasing awareness about the importance of vaccination, rising investments in healthcare infrastructure, expanding immunization programs in developing countries, and technological advancements in vaccine development.
One of the key trends shaping the vaccine market is the growing demand for novel vaccines targeting emerging infectious diseases such as COVID-19. The pandemic has highlighted the importance of vaccine research and development, leading to increased funding and collaborations in the industry. Furthermore, there is a shift towards personalized vaccines and the use of mRNA technology, which has shown promising results in vaccine efficacy.
Another trend is the focus on preventive healthcare, with governments and healthcare organizations emphasizing the importance of vaccination in reducing the burden of infectious diseases. This trend is driving the development of new vaccines and expanding the market reach to previously underserved populations.
Regional market distribution plays a significant role in the vaccine market, with North America and Europe leading in terms of market share. The dominance of these regions can be attributed to factors such as high healthcare expenditure, strong regulatory frameworks, and robust research infrastructure. In contrast, developing regions like Asia-Pacific and Latin America are witnessing rapid market growth due to increasing investments in healthcare and rising awareness about vaccination benefits.
Despite the positive outlook, the vaccine market faces several challenges. One of the key challenges is vaccine hesitancy, fueled by misinformation and lack of trust in vaccines. Addressing this challenge requires targeted communication strategies, transparent information sharing, and collaboration between healthcare providers and communities. Additionally, supply chain disruptions, regulatory hurdles, and vaccine pricing pressures pose significant challenges to market growth and accessibility.
In conclusion, the global vaccine market is poised for substantial growth driven by increasing awareness, technological advancements, and expanding immunization programs. To capitalize on this growth, stakeholders must address challenges such as vaccine hesitancy, ensure supply chain resilience, and prioritize research and development efforts to meet evolving healthcare needs.
This report provides a deep insight into the global Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine market in any manner.
Global Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Market Segmentation (by Type)
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
by Application
Market Segmentation (by Application)
For Adult
For Child
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Vaccines play a crucial role in preventing and controlling infectious diseases by stimulating the immune system to recognize and fight specific pathogens. The global vaccine market encompasses a wide range of products designed to prevent various diseases, including but not limited to influenza, hepatitis, measles, and human papillomavirus.
As of 2023, the global vaccine market size stands at approximately $60 billion. The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.5% from 2024 to 2032. Several factors are driving this growth, including increasing awareness about the importance of vaccination, rising investments in healthcare infrastructure, expanding immunization programs in developing countries, and technological advancements in vaccine development.
One of the key trends shaping the vaccine market is the growing demand for novel vaccines targeting emerging infectious diseases such as COVID-19. The pandemic has highlighted the importance of vaccine research and development, leading to increased funding and collaborations in the industry. Furthermore, there is a shift towards personalized vaccines and the use of mRNA technology, which has shown promising results in vaccine efficacy.
Another trend is the focus on preventive healthcare, with governments and healthcare organizations emphasizing the importance of vaccination in reducing the burden of infectious diseases. This trend is driving the development of new vaccines and expanding the market reach to previously underserved populations.
Regional market distribution plays a significant role in the vaccine market, with North America and Europe leading in terms of market share. The dominance of these regions can be attributed to factors such as high healthcare expenditure, strong regulatory frameworks, and robust research infrastructure. In contrast, developing regions like Asia-Pacific and Latin America are witnessing rapid market growth due to increasing investments in healthcare and rising awareness about vaccination benefits.
Despite the positive outlook, the vaccine market faces several challenges. One of the key challenges is vaccine hesitancy, fueled by misinformation and lack of trust in vaccines. Addressing this challenge requires targeted communication strategies, transparent information sharing, and collaboration between healthcare providers and communities. Additionally, supply chain disruptions, regulatory hurdles, and vaccine pricing pressures pose significant challenges to market growth and accessibility.
In conclusion, the global vaccine market is poised for substantial growth driven by increasing awareness, technological advancements, and expanding immunization programs. To capitalize on this growth, stakeholders must address challenges such as vaccine hesitancy, ensure supply chain resilience, and prioritize research and development efforts to meet evolving healthcare needs.
This report provides a deep insight into the global Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Vaccine market in any manner.
Global Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties
Market Segmentation (by Type)
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others
by Application
Market Segmentation (by Application)
For Adult
For Child
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Vaccine Market
- Overview of the regional outlook of the Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Vaccine
1.2 Key Market Segments
1.2.1 Vaccine Segment by Type
1.2.2 Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine Sales Sites, Area Served, Product Type
3.6 Vaccine Market Competitive Situation and Trends
3.6.1 Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine Price by Type (2019-2024)
7 VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine Market Sales by Application (2019-2024)
7.3 Global Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine Sales Growth Rate by Application (2019-2024)
8 VACCINE MARKET SALES BY REGION
8.1 Global Vaccine Sales by Region
8.1.1 Global Vaccine Sales by Region
8.1.2 Global Vaccine Sales Market Share by Region
8.2 Global Vaccine Market Size by Region
8.2.1 Global Vaccine Market Size by Region
8.2.2 Global Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Vaccine Sales by Country
8.3.2 North America Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaccine Sales by Country
8.4.2 Europe Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaccine Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Vaccine Market Size by Region
8.6.2 Asia Pacific Vaccine Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Vaccine Sales by Country
8.7.2 South America Vaccine Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Vaccine Sales by Region
8.8.2 Middle East and Africa Vaccine Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccine by Region (2019-2024)
9.2 Global Vaccine Revenue Market Share by Region (2019-2024)
9.3 Global Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Vaccine Production
9.4.1 North America Vaccine Production Growth Rate (2019-2024)
9.4.2 North America Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Vaccine Production
9.5.1 Europe Vaccine Production Growth Rate (2019-2024)
9.5.2 Europe Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Vaccine Production (2019-2024)
9.6.1 Japan Vaccine Production Growth Rate (2019-2024)
9.6.2 Japan Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Vaccine Production (2019-2024)
9.7.1 China Vaccine Production Growth Rate (2019-2024)
9.7.2 China Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca
10.1.1 AstraZeneca Vaccine Basic Information
10.1.2 AstraZeneca Vaccine Product Overview
10.1.3 AstraZeneca Vaccine Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca Vaccine SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 BioNTech
10.2.1 BioNTech Vaccine Basic Information
10.2.2 BioNTech Vaccine Product Overview
10.2.3 BioNTech Vaccine Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech Vaccine SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 Boehringer-Ingelheim
10.3.1 Boehringer-Ingelheim Vaccine Basic Information
10.3.2 Boehringer-Ingelheim Vaccine Product Overview
10.3.3 Boehringer-Ingelheim Vaccine Product Market Performance
10.3.4 Boehringer-Ingelheim Vaccine SWOT Analysis
10.3.5 Boehringer-Ingelheim Business Overview
10.3.6 Boehringer-Ingelheim Recent Developments
10.4 CCBIO
10.4.1 CCBIO Vaccine Basic Information
10.4.2 CCBIO Vaccine Product Overview
10.4.3 CCBIO Vaccine Product Market Performance
10.4.4 CCBIO Business Overview
10.4.5 CCBIO Recent Developments
10.5 CSL
10.5.1 CSL Vaccine Basic Information
10.5.2 CSL Vaccine Product Overview
10.5.3 CSL Vaccine Product Market Performance
10.5.4 CSL Business Overview
10.5.5 CSL Recent Developments
10.6 CureVac
10.6.1 CureVac Vaccine Basic Information
10.6.2 CureVac Vaccine Product Overview
10.6.3 CureVac Vaccine Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Elanco
10.7.1 Elanco Vaccine Basic Information
10.7.2 Elanco Vaccine Product Overview
10.7.3 Elanco Vaccine Product Market Performance
10.7.4 Elanco Business Overview
10.7.5 Elanco Recent Developments
10.8 GSK
10.8.1 GSK Vaccine Basic Information
10.8.2 GSK Vaccine Product Overview
10.8.3 GSK Vaccine Product Market Performance
10.8.4 GSK Business Overview
10.8.5 GSK Recent Developments
10.9 Hulan Bio
10.9.1 Hulan Bio Vaccine Basic Information
10.9.2 Hulan Bio Vaccine Product Overview
10.9.3 Hulan Bio Vaccine Product Market Performance
10.9.4 Hulan Bio Business Overview
10.9.5 Hulan Bio Recent Developments
10.10 Indian Immunologicals
10.10.1 Indian Immunologicals Vaccine Basic Information
10.10.2 Indian Immunologicals Vaccine Product Overview
10.10.3 Indian Immunologicals Vaccine Product Market Performance
10.10.4 Indian Immunologicals Business Overview
10.10.5 Indian Immunologicals Recent Developments
10.11 Merck
10.11.1 Merck Vaccine Basic Information
10.11.2 Merck Vaccine Product Overview
10.11.3 Merck Vaccine Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Minhai Biotechnology
10.12.1 Minhai Biotechnology Vaccine Basic Information
10.12.2 Minhai Biotechnology Vaccine Product Overview
10.12.3 Minhai Biotechnology Vaccine Product Market Performance
10.12.4 Minhai Biotechnology Business Overview
10.12.5 Minhai Biotechnology Recent Developments
10.13 Mitsubishi Tanabe Pharma
10.13.1 Mitsubishi Tanabe Pharma Vaccine Basic Information
10.13.2 Mitsubishi Tanabe Pharma Vaccine Product Overview
10.13.3 Mitsubishi Tanabe Pharma Vaccine Product Market Performance
10.13.4 Mitsubishi Tanabe Pharma Business Overview
10.13.5 Mitsubishi Tanabe Pharma Recent Developments
10.14 Moderna Therapeutics
10.14.1 Moderna Therapeutics Vaccine Basic Information
10.14.2 Moderna Therapeutics Vaccine Product Overview
10.14.3 Moderna Therapeutics Vaccine Product Market Performance
10.14.4 Moderna Therapeutics Business Overview
10.14.5 Moderna Therapeutics Recent Developments
10.15 Mylan
10.15.1 Mylan Vaccine Basic Information
10.15.2 Mylan Vaccine Product Overview
10.15.3 Mylan Vaccine Product Market Performance
10.15.4 Mylan Business Overview
10.15.5 Mylan Recent Developments
10.16 Plumbline Life Sciences
10.16.1 Plumbline Life Sciences Vaccine Basic Information
10.16.2 Plumbline Life Sciences Vaccine Product Overview
10.16.3 Plumbline Life Sciences Vaccine Product Market Performance
10.16.4 Plumbline Life Sciences Business Overview
10.16.5 Plumbline Life Sciences Recent Developments
10.17 Sanofi
10.17.1 Sanofi Vaccine Basic Information
10.17.2 Sanofi Vaccine Product Overview
10.17.3 Sanofi Vaccine Product Market Performance
10.17.4 Sanofi Business Overview
10.17.5 Sanofi Recent Developments
10.18 Translate Bio
10.18.1 Translate Bio Vaccine Basic Information
10.18.2 Translate Bio Vaccine Product Overview
10.18.3 Translate Bio Vaccine Product Market Performance
10.18.4 Translate Bio Business Overview
10.18.5 Translate Bio Recent Developments
10.19 Walvax Biotechnology
10.19.1 Walvax Biotechnology Vaccine Basic Information
10.19.2 Walvax Biotechnology Vaccine Product Overview
10.19.3 Walvax Biotechnology Vaccine Product Market Performance
10.19.4 Walvax Biotechnology Business Overview
10.19.5 Walvax Biotechnology Recent Developments
10.20 Wuhan Institute of Biological Products
10.20.1 Wuhan Institute of Biological Products Vaccine Basic Information
10.20.2 Wuhan Institute of Biological Products Vaccine Product Overview
10.20.3 Wuhan Institute of Biological Products Vaccine Product Market Performance
10.20.4 Wuhan Institute of Biological Products Business Overview
10.20.5 Wuhan Institute of Biological Products Recent Developments
10.21 Zoties
10.21.1 Zoties Vaccine Basic Information
10.21.2 Zoties Vaccine Product Overview
10.21.3 Zoties Vaccine Product Market Performance
10.21.4 Zoties Business Overview
10.21.5 Zoties Recent Developments
11 VACCINE MARKET FORECAST BY REGION
11.1 Global Vaccine Market Size Forecast
11.2 Global Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Vaccine Market Size Forecast by Region
11.2.4 South America Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Vaccine by Type (2025-2032)
12.1.2 Global Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Vaccine by Type (2025-2032)
12.2 Global Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Vaccine
1.2 Key Market Segments
1.2.1 Vaccine Segment by Type
1.2.2 Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
2.4 Macroeconomic Analysis
3 VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Vaccine Sales Sites, Area Served, Product Type
3.6 Vaccine Market Competitive Situation and Trends
3.6.1 Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Vaccine Price by Type (2019-2024)
7 VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Vaccine Market Sales by Application (2019-2024)
7.3 Global Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Vaccine Sales Growth Rate by Application (2019-2024)
8 VACCINE MARKET SALES BY REGION
8.1 Global Vaccine Sales by Region
8.1.1 Global Vaccine Sales by Region
8.1.2 Global Vaccine Sales Market Share by Region
8.2 Global Vaccine Market Size by Region
8.2.1 Global Vaccine Market Size by Region
8.2.2 Global Vaccine Market Size Market Share by Region
8.3 North America
8.3.1 North America Vaccine Sales by Country
8.3.2 North America Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Vaccine Sales by Country
8.4.2 Europe Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Russia Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Vaccine Sales by Region
8.5.2 China
8.5.3 Japan
8.5.4 South Korea
8.5.5 India
8.5.6 Southeast Asia
8.6 Asia Pacific
8.6.1 Asia Pacific Vaccine Market Size by Region
8.6.2 Asia Pacific Vaccine Market Size by Region
8.6.3 China
8.6.4 Japan
8.6.5 South Korea
8.6.6 India
8.6.7 Southeast Asia
8.7 South America
8.7.1 South America Vaccine Sales by Country
8.7.2 South America Vaccine Market Size by Country
8.7.3 Brazil
8.7.4 Argentina
8.7.5 Columbia
8.8 Middle East and Africa
8.8.1 Middle East and Africa Vaccine Sales by Region
8.8.2 Middle East and Africa Vaccine Market Size by Region
8.8.3 Saudi Arabia
8.8.4 UAE
8.8.5 Egypt
8.8.6 Nigeria
8.8.7 South Africa
9 VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Vaccine by Region (2019-2024)
9.2 Global Vaccine Revenue Market Share by Region (2019-2024)
9.3 Global Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Vaccine Production
9.4.1 North America Vaccine Production Growth Rate (2019-2024)
9.4.2 North America Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Vaccine Production
9.5.1 Europe Vaccine Production Growth Rate (2019-2024)
9.5.2 Europe Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Vaccine Production (2019-2024)
9.6.1 Japan Vaccine Production Growth Rate (2019-2024)
9.6.2 Japan Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Vaccine Production (2019-2024)
9.7.1 China Vaccine Production Growth Rate (2019-2024)
9.7.2 China Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca
10.1.1 AstraZeneca Vaccine Basic Information
10.1.2 AstraZeneca Vaccine Product Overview
10.1.3 AstraZeneca Vaccine Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca Vaccine SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 BioNTech
10.2.1 BioNTech Vaccine Basic Information
10.2.2 BioNTech Vaccine Product Overview
10.2.3 BioNTech Vaccine Product Market Performance
10.2.4 BioNTech Business Overview
10.2.5 BioNTech Vaccine SWOT Analysis
10.2.6 BioNTech Recent Developments
10.3 Boehringer-Ingelheim
10.3.1 Boehringer-Ingelheim Vaccine Basic Information
10.3.2 Boehringer-Ingelheim Vaccine Product Overview
10.3.3 Boehringer-Ingelheim Vaccine Product Market Performance
10.3.4 Boehringer-Ingelheim Vaccine SWOT Analysis
10.3.5 Boehringer-Ingelheim Business Overview
10.3.6 Boehringer-Ingelheim Recent Developments
10.4 CCBIO
10.4.1 CCBIO Vaccine Basic Information
10.4.2 CCBIO Vaccine Product Overview
10.4.3 CCBIO Vaccine Product Market Performance
10.4.4 CCBIO Business Overview
10.4.5 CCBIO Recent Developments
10.5 CSL
10.5.1 CSL Vaccine Basic Information
10.5.2 CSL Vaccine Product Overview
10.5.3 CSL Vaccine Product Market Performance
10.5.4 CSL Business Overview
10.5.5 CSL Recent Developments
10.6 CureVac
10.6.1 CureVac Vaccine Basic Information
10.6.2 CureVac Vaccine Product Overview
10.6.3 CureVac Vaccine Product Market Performance
10.6.4 CureVac Business Overview
10.6.5 CureVac Recent Developments
10.7 Elanco
10.7.1 Elanco Vaccine Basic Information
10.7.2 Elanco Vaccine Product Overview
10.7.3 Elanco Vaccine Product Market Performance
10.7.4 Elanco Business Overview
10.7.5 Elanco Recent Developments
10.8 GSK
10.8.1 GSK Vaccine Basic Information
10.8.2 GSK Vaccine Product Overview
10.8.3 GSK Vaccine Product Market Performance
10.8.4 GSK Business Overview
10.8.5 GSK Recent Developments
10.9 Hulan Bio
10.9.1 Hulan Bio Vaccine Basic Information
10.9.2 Hulan Bio Vaccine Product Overview
10.9.3 Hulan Bio Vaccine Product Market Performance
10.9.4 Hulan Bio Business Overview
10.9.5 Hulan Bio Recent Developments
10.10 Indian Immunologicals
10.10.1 Indian Immunologicals Vaccine Basic Information
10.10.2 Indian Immunologicals Vaccine Product Overview
10.10.3 Indian Immunologicals Vaccine Product Market Performance
10.10.4 Indian Immunologicals Business Overview
10.10.5 Indian Immunologicals Recent Developments
10.11 Merck
10.11.1 Merck Vaccine Basic Information
10.11.2 Merck Vaccine Product Overview
10.11.3 Merck Vaccine Product Market Performance
10.11.4 Merck Business Overview
10.11.5 Merck Recent Developments
10.12 Minhai Biotechnology
10.12.1 Minhai Biotechnology Vaccine Basic Information
10.12.2 Minhai Biotechnology Vaccine Product Overview
10.12.3 Minhai Biotechnology Vaccine Product Market Performance
10.12.4 Minhai Biotechnology Business Overview
10.12.5 Minhai Biotechnology Recent Developments
10.13 Mitsubishi Tanabe Pharma
10.13.1 Mitsubishi Tanabe Pharma Vaccine Basic Information
10.13.2 Mitsubishi Tanabe Pharma Vaccine Product Overview
10.13.3 Mitsubishi Tanabe Pharma Vaccine Product Market Performance
10.13.4 Mitsubishi Tanabe Pharma Business Overview
10.13.5 Mitsubishi Tanabe Pharma Recent Developments
10.14 Moderna Therapeutics
10.14.1 Moderna Therapeutics Vaccine Basic Information
10.14.2 Moderna Therapeutics Vaccine Product Overview
10.14.3 Moderna Therapeutics Vaccine Product Market Performance
10.14.4 Moderna Therapeutics Business Overview
10.14.5 Moderna Therapeutics Recent Developments
10.15 Mylan
10.15.1 Mylan Vaccine Basic Information
10.15.2 Mylan Vaccine Product Overview
10.15.3 Mylan Vaccine Product Market Performance
10.15.4 Mylan Business Overview
10.15.5 Mylan Recent Developments
10.16 Plumbline Life Sciences
10.16.1 Plumbline Life Sciences Vaccine Basic Information
10.16.2 Plumbline Life Sciences Vaccine Product Overview
10.16.3 Plumbline Life Sciences Vaccine Product Market Performance
10.16.4 Plumbline Life Sciences Business Overview
10.16.5 Plumbline Life Sciences Recent Developments
10.17 Sanofi
10.17.1 Sanofi Vaccine Basic Information
10.17.2 Sanofi Vaccine Product Overview
10.17.3 Sanofi Vaccine Product Market Performance
10.17.4 Sanofi Business Overview
10.17.5 Sanofi Recent Developments
10.18 Translate Bio
10.18.1 Translate Bio Vaccine Basic Information
10.18.2 Translate Bio Vaccine Product Overview
10.18.3 Translate Bio Vaccine Product Market Performance
10.18.4 Translate Bio Business Overview
10.18.5 Translate Bio Recent Developments
10.19 Walvax Biotechnology
10.19.1 Walvax Biotechnology Vaccine Basic Information
10.19.2 Walvax Biotechnology Vaccine Product Overview
10.19.3 Walvax Biotechnology Vaccine Product Market Performance
10.19.4 Walvax Biotechnology Business Overview
10.19.5 Walvax Biotechnology Recent Developments
10.20 Wuhan Institute of Biological Products
10.20.1 Wuhan Institute of Biological Products Vaccine Basic Information
10.20.2 Wuhan Institute of Biological Products Vaccine Product Overview
10.20.3 Wuhan Institute of Biological Products Vaccine Product Market Performance
10.20.4 Wuhan Institute of Biological Products Business Overview
10.20.5 Wuhan Institute of Biological Products Recent Developments
10.21 Zoties
10.21.1 Zoties Vaccine Basic Information
10.21.2 Zoties Vaccine Product Overview
10.21.3 Zoties Vaccine Product Market Performance
10.21.4 Zoties Business Overview
10.21.5 Zoties Recent Developments
11 VACCINE MARKET FORECAST BY REGION
11.1 Global Vaccine Market Size Forecast
11.2 Global Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Vaccine Market Size Forecast by Region
11.2.4 South America Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Vaccine by Type (2025-2032)
12.1.2 Global Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Vaccine by Type (2025-2032)
12.2 Global Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
